Showing results (61-70 of 121) with videos related to
Sort By:
Pageof 13
Radiation Oncology (London, England)|February 14, 2015
Impact of weight loss on survival after chemoradiation for locally advanced head and neck cancer: secondary results of a randomized phase III trial (SAKK 10/94)Pirus Ghadjar, Stefanie Hayoz, Frank Zimmermann, et al.Radiation Oncology (London, England)|December 13, 2023
Histopathologically confirmed radiation-induced damage of the brain - an in-depth analysis of radiation parameters and spatio-temporal occurrenceMario R P Kossmann, Felix Ehret, Siyer Roohani, et al.Acta Radiologica (Stockholm, Sweden : 1987)|September 17, 2020
Quantitative volumetric assessment of baseline enhancing tumor volume as an imaging biomarker predicts overall survival in patients with glioblastomaTimo A Auer, Marta Della Seta, Federico Collettini, et al.Frontiers in Oncology|February 13, 2024
Robotic stereotactic radiosurgery for intracranial meningiomas in elderly patients: assessment of treatment efficacy and safetyAnton Früh, Bohdan Bodnar, Marcel Nachbar, et al.Journal of Immunology (Baltimore, Md. : 1950)|June 30, 2012
Extracellularly delivered single-stranded viral RNA causes neurodegeneration dependent on TLR7Sabrina M Lehmann, Karen Rosenberger, Christina Krüger, et al.Plos One|June 6, 2012
Expression of Toll-like receptors in the developing brainDavid Kaul, Piet Habbel, Katja Derkow, et al.Frontiers in Oncology|May 17, 2021
Image-Guided Robotic Radiosurgery for the Management of Spinal EpendymomasFelix Ehret, Markus Kufeld, Christoph Fürweger, et al.Journal of Neuro-Oncology|February 20, 2024
Validation of a methylation-based signature for subventricular zone involvement in glioblastomaFelix Ehret, Oliver Zühlke, Leonille Schweizer, et al.Journal of Neuro-Oncology|March 23, 2024
Adjuvant re-irradiation vs. no early re-irradiation of resected recurrent glioblastoma: pooled comparative cohort analysis from two tertiary centersChristoph Straube, Stephanie E Combs, Denise Bernhardt, et al.BMC Cancer|January 31, 2020
Combination therapy with Olaratumab/doxorubicin in advanced or metastatic soft tissue sarcoma -a single-Centre experienceJana Käthe Striefler, Franziska Brandes, Alexander Baur, et al.Pageof 13